Copyright Reports & Markets. All rights reserved.

Global and United States IPV Vaccine Market Report & Forecast 2022-2028

Request for Sample of this report
Buy now

Table of Contents

    1 Study Coverage

    • 1.1 IPV Vaccine Product Introduction
    • 1.2 Global IPV Vaccine Outlook 2017 VS 2022 VS 2028
      • 1.2.1 Global IPV Vaccine Sales in US$ Million for the Year 2017-2028
      • 1.2.2 Global IPV Vaccine Sales in Volume for the Year 2017-2028
    • 1.3 United States IPV Vaccine Outlook 2017 VS 2022 VS 2028
      • 1.3.1 United States IPV Vaccine Sales in US$ Million for the Year 2017-2028
      • 1.3.2 United States IPV Vaccine Sales in Volume for the Year 2017-2028
    • 1.4 IPV Vaccine Market Size, United States VS Global, 2017 VS 2022 VS 2028
      • 1.4.1 The Market Share of United States IPV Vaccine in Global, 2017 VS 2022 VS 2028
      • 1.4.2 The Growth Rate of IPV Vaccine Market Size, United States VS Global, 2017 VS 2022 VS 2028
    • 1.5 IPV Vaccine Market Dynamics
      • 1.5.1 IPV Vaccine Industry Trends
      • 1.5.2 IPV Vaccine Market Drivers
      • 1.5.3 IPV Vaccine Market Challenges
      • 1.5.4 IPV Vaccine Market Restraints
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Market by Type

    • 2.1 IPV Vaccine Market Segment by Type
      • 2.1.1 Mahoney
      • 2.1.2 MEF1
      • 2.1.3 Saukett
    • 2.2 Global IPV Vaccine Market Size by Type
      • 2.2.1 Global IPV Vaccine Sales in Value, by Type (2017, 2022 & 2028)
      • 2.2.2 Global IPV Vaccine Sales in Volume, by Type (2017, 2022 & 2028)
      • 2.2.3 Global IPV Vaccine Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    • 2.3 United States IPV Vaccine Market Size by Type
      • 2.3.1 United States IPV Vaccine Sales in Value, by Type (2017, 2022 & 2028)
      • 2.3.2 United States IPV Vaccine Sales in Volume, by Type (2017, 2022 & 2028)
      • 2.3.3 United States IPV Vaccine Average Selling Price (ASP) by Type (2017, 2022 & 2028)

    3 Market by Application

    • 3.1 IPV Vaccine Market Segment by Application
      • 3.1.1 Private Distribution Channel
      • 3.1.2 Public Distribution Channel
    • 3.2 Global IPV Vaccine Market Size by Application
      • 3.2.1 Global IPV Vaccine Sales in Value, by Application (2017, 2022 & 2028)
      • 3.2.2 Global IPV Vaccine Sales in Volume, by Application (2017, 2022 & 2028)
      • 3.3.3 Global IPV Vaccine Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    • 3.3 United States IPV Vaccine Market Size by Application
      • 3.3.1 United States IPV Vaccine Sales in Value, by Application (2017, 2022 & 2028)
      • 3.3.2 United States IPV Vaccine Sales in Volume, by Application (2017, 2022 & 2028)
      • 3.3.3 United States IPV Vaccine Average Selling Price (ASP) by Application (2017, 2022 & 2028)

    4 Global IPV Vaccine Competitor Landscape by Company

    • 4.1 Global IPV Vaccine Market Size by Company
      • 4.1.1 Top Global IPV Vaccine Manufacturers Ranked by Revenue (2021)
      • 4.1.2 Global IPV Vaccine Revenue by Manufacturer (2017-2022)
      • 4.1.3 Global IPV Vaccine Sales by Manufacturer (2017-2022)
      • 4.1.4 Global IPV Vaccine Price by Manufacturer (2017-2022)
    • 4.2 Global IPV Vaccine Concentration Ratio (CR)
      • 4.2.1 IPV Vaccine Market Concentration Ratio (CR) (2017-2022)
      • 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of IPV Vaccine in 2021
      • 4.2.3 Global IPV Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 4.3 Global IPV Vaccine Manufacturing Base Distribution, Product Type
      • 4.3.1 Global IPV Vaccine Manufacturers, Headquarters and Distribution of Producing Region
      • 4.3.2 Manufacturers IPV Vaccine Product Type
      • 4.3.3 Date of International Manufacturers Enter into IPV Vaccine Market
    • 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    • 4.5 United States IPV Vaccine Market Size by Company
      • 4.5.1 Top IPV Vaccine Players in United States, Ranked by Revenue (2021)
      • 4.5.2 United States IPV Vaccine Revenue by Players (2020, 2021 & 2022)
      • 4.5.3 United States IPV Vaccine Sales by Players (2020, 2021 & 2022)

    5 Global IPV Vaccine Market Size by Region

    • 5.1 Global IPV Vaccine Market Size by Region: 2017 VS 2022 VS 2028
    • 5.2 Global IPV Vaccine Market Size in Volume by Region (2017-2028)
      • 5.2.1 Global IPV Vaccine Sales in Volume by Region: 2017-2022
      • 5.2.2 Global IPV Vaccine Sales in Volume Forecast by Region (2023-2028)
    • 5.3 Global IPV Vaccine Market Size in Value by Region (2017-2028)
      • 5.3.1 Global IPV Vaccine Sales in Value by Region: 2017-2022
      • 5.3.2 Global IPV Vaccine Sales in Value by Region: 2023-2028

    6 Segment in Region Level & Country Level

    • 6.1 North America
      • 6.1.1 North America IPV Vaccine Market Size YoY Growth 2017-2028
      • 6.1.2 North America IPV Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.1.3 United States
      • 6.1.4 Canada
    • 6.2 Asia-Pacific
      • 6.2.1 Asia-Pacific IPV Vaccine Market Size YoY Growth 2017-2028
      • 6.2.2 Asia-Pacific IPV Vaccine Market Facts & Figures by Region (2017, 2022 & 2028)
      • 6.2.3 China
      • 6.2.4 Japan
      • 6.2.5 South Korea
      • 6.2.6 India
      • 6.2.7 Australia
      • 6.2.8 China Taiwan
      • 6.2.9 Indonesia
      • 6.2.10 Thailand
      • 6.2.11 Malaysia
    • 6.3 Europe
      • 6.3.1 Europe IPV Vaccine Market Size YoY Growth 2017-2028
      • 6.3.2 Europe IPV Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.3.3 Germany
      • 6.3.4 France
      • 6.3.5 U.K.
      • 6.3.6 Italy
      • 6.3.7 Russia
    • 6.4 Latin America
      • 6.4.1 Latin America IPV Vaccine Market Size YoY Growth 2017-2028
      • 6.4.2 Latin America IPV Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.4.3 Mexico
      • 6.4.4 Brazil
      • 6.4.5 Argentina
      • 6.4.6 Colombia
    • 6.5 Middle East and Africa
      • 6.5.1 Middle East and Africa IPV Vaccine Market Size YoY Growth 2017-2028
      • 6.5.2 Middle East and Africa IPV Vaccine Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.5.3 Turkey
      • 6.5.4 Saudi Arabia
      • 6.5.5 UAE

    7 Company Profiles

    • 7.1 GlaxoSmithKline Plc
      • 7.1.1 GlaxoSmithKline Plc Corporation Information
      • 7.1.2 GlaxoSmithKline Plc Description and Business Overview
      • 7.1.3 GlaxoSmithKline Plc IPV Vaccine Sales, Revenue and Gross Margin (2017-2022)
      • 7.1.4 GlaxoSmithKline Plc IPV Vaccine Products Offered
      • 7.1.5 GlaxoSmithKline Plc Recent Development
    • 7.2 Sanofi S.A
      • 7.2.1 Sanofi S.A Corporation Information
      • 7.2.2 Sanofi S.A Description and Business Overview
      • 7.2.3 Sanofi S.A IPV Vaccine Sales, Revenue and Gross Margin (2017-2022)
      • 7.2.4 Sanofi S.A IPV Vaccine Products Offered
      • 7.2.5 Sanofi S.A Recent Development
    • 7.3 Serum Institute of India Pvt. Ltd.
      • 7.3.1 Serum Institute of India Pvt. Ltd. Corporation Information
      • 7.3.2 Serum Institute of India Pvt. Ltd. Description and Business Overview
      • 7.3.3 Serum Institute of India Pvt. Ltd. IPV Vaccine Sales, Revenue and Gross Margin (2017-2022)
      • 7.3.4 Serum Institute of India Pvt. Ltd. IPV Vaccine Products Offered
      • 7.3.5 Serum Institute of India Pvt. Ltd. Recent Development
    • 7.4 PT Bio Farma
      • 7.4.1 PT Bio Farma Corporation Information
      • 7.4.2 PT Bio Farma Description and Business Overview
      • 7.4.3 PT Bio Farma IPV Vaccine Sales, Revenue and Gross Margin (2017-2022)
      • 7.4.4 PT Bio Farma IPV Vaccine Products Offered
      • 7.4.5 PT Bio Farma Recent Development
    • 7.5 AJ Vaccines
      • 7.5.1 AJ Vaccines Corporation Information
      • 7.5.2 AJ Vaccines Description and Business Overview
      • 7.5.3 AJ Vaccines IPV Vaccine Sales, Revenue and Gross Margin (2017-2022)
      • 7.5.4 AJ Vaccines IPV Vaccine Products Offered
      • 7.5.5 AJ Vaccines Recent Development

    8 Industry Chain and Sales Channels Analysis

    • 8.1 IPV Vaccine Industry Chain Analysis
    • 8.2 IPV Vaccine Key Raw Materials
      • 8.2.1 Key Raw Materials
      • 8.2.2 IPV Vaccine Distributors
    • 8.3 IPV Vaccine Production Mode & Process
    • 8.4 IPV Vaccine Sales and Marketing
      • 8.4.1 IPV Vaccine Sales Channels
      • 8.4.2 IPV Vaccine Distributors
    • 8.5 IPV Vaccine Customers

    9 Research Findings and Conclusion

      10 Appendix

      • 10.1 Research Methodology
        • 10.1.1 Methodology/Research Approach
        • 10.1.2 Data Source
      • 10.2 Author Details

      Summary:

      Market Analysis and Insights: Global and United States IPV Vaccine Market
      This report focuses on global and United States IPV Vaccine market, also covers the segmentation data of other regions in regional level and county level.
      Due to the COVID-19 pandemic, the global IPV Vaccine market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, by Type, Mahoney accounting for % of the IPV Vaccine global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While by Application, Private Distribution Channel was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
      In United States the IPV Vaccine market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
      Global IPV Vaccine Scope and Market Size
      IPV Vaccine market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global IPV Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
      For United States market, this report focuses on the IPV Vaccine market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
      Segment by Type, the IPV Vaccine market is segmented into
      Mahoney
      MEF1
      Saukett
      Segment by Application, the IPV Vaccine market is segmented into
      Private Distribution Channel
      Public Distribution Channel
      Regional and Country-level Analysis
      By Region
      North America
      United States
      Canada
      Europe
      Germany
      France
      U.K.
      Italy
      Russia
      Asia-Pacific
      China
      Japan
      South Korea
      India
      Australia
      China Taiwan
      Indonesia
      Thailand
      Malaysia
      Latin America
      Mexico
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Turkey
      Saudi Arabia
      UAE
      Competitive Landscape and IPV Vaccine Market Share Analysis
      IPV Vaccine market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in IPV Vaccine business, the date to enter into the IPV Vaccine market, IPV Vaccine product introduction, recent developments, etc.
      The major vendors covered:
      GlaxoSmithKline Plc
      Sanofi S.A
      Serum Institute of India Pvt. Ltd.
      PT Bio Farma
      AJ Vaccines
      Buy now